Anti-CD3 & FCRL5 Antibody (Cevostamab)

Anti-CD3 & FCRL5 Antibody (Cevostamab)

Author: ApexBio

spu:

F1305

CAS:

2249888-53-5

purity:

> 90% by SDS-PAGE and SEC-HPLC analyses.

shortsummary:

Anti-CD3 & FCRL5 Antibody (Cevostamab)

VEGF receptor inhibitor and AHR agonist

M.Wt:

146.19 kDa

Storage:

-80°C

DeliveryTime:

Ship with 3-5 days

278779-30-9 APExBIO

ShippingType:

Dry ice

description:

Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized, IgG1-based BsAb that targets the membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells and CD3 on T cells. In addition, Cevostamab promotes the formation of effective synapses and enhances the cytotoxic activity of T cells against MM tumor cells.

related websites:

APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 17629 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.